Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| AMERICAN RCT REIT (NASDAQ: ARCT) | Delayed: 10.22 -0.51 (4.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.73 | 52 Week High | $13.09 | |||
| Open | $10.59 | 52 Week Low | $5.54 | |||
| Day High | $10.69 | P/E | N/A | |||
| Day Low | $9.91 | EPS | $-0.38 | |||
| Volume | 118,599 | |||||
